ICAM1 and neoplasm: Although the clinical activity as single agent is modest, it has been shown that anti-angiogenic drugs could normalize the tumor vasculature and increase T cell infiltration by inducing the upregulation of the leukocyte adhesion molecules such as ICAM-1 and VCAM-1 on tumor endothelial cells (34).